Endothelial progenitor cells (EPC) are a population of cells that circulate in the blood stream. They play a role in angiogenesis and, therefore, can be prognostic markers of vascular repair. Ginsenoside Rg 3 prevents endothelial cell apoptosis through the inhibition of the mitochondrial caspase pathway. It also affects estrogen activity, which reduces EPC senescence. Sun ginseng (SG), which is heat-processed ginseng, has a high content of ginsenosides. The purpose of this study was to investigate the protective effects of SG on senescence-associated apoptosis in EPCs. In order to isolate EPCs, mononuclear cells of human blood buffy coats were cultured and characterized by their uptake of acetylated low-density lipoprotein (acLDL) and their binding of Ulex europaeus agglutinin I (ulex-lectin). Flow cytometry with annexin-V staining was performed in order to assess early and late apoptosis. Senescence was determined by β-galactosidase (β-gal) staining. Staining with 4′-6-Diamidino-2-phenylindole verifi ed that most adherent cells (93±2.7%) were acLDL-positive and ulex-lectin-positive. The percentage of β-gal-positive EPCs was decreased from 93.8±2.0% to 62.5±3.6% by SG treatment. A fl uorescence-activated cell sorter (FACS) analysis showed that 4.9% of EPCs were late apoptotic in controls. Sun ginseng decreased the apoptotic cell population by 39% in the late stage of apoptosis from control baseline levels. In conclusion, these results show antisenescent and antiapoptotic effects of SG in human-derived EPCs, indicating that SG can enhance EPC-mediated repair mechanisms.
INTRODUCTION
Bone-marrow-derived endothelial progenitor cells (EPCs) play an integral role in the regulation and protection of the endothelium. EPCs from peripheral blood can also enhance angiogenesis when they are infused into host animals [1, 2] . The number of EPCs can be used as a surrogate biologic marker of vascular function, and the number of EPCs is inversely correlated with the cumulative cardiovascular risk [3] [4] [5] [6] [7] . In addition, reduced numbers of EPCs in patients with cerebrovascular dysfunctions have been noted [8, 9] , suggesting that the number of EPCs can be a biological marker in patients with migraine, ischemic strokes, cerebral large artery atherosclerosis, and even in Alzheimer's disease (AD) [8] .
Sun ginseng (SG), which is processed at 120°C, results in an increased production of ginsenoside Rg 3 , Rg 5 , and Rk 1 . This processed ginseng includes ingredients, such as ginsenoside Rk 2 , Rk 3 , Rs 4 , Rs 5 , Rs 6 , and Rs 7 [10] [11] [12] [13] . These ginsenosides protect endothelial cells (ECs) from apoptosis through the inhibition of mitochondrial caspase. ECs undergo apoptosis and exhibit increased levels of caspase-9 and caspase-3 activities and DNA fragmentation after 24 h of serum deprivation. However, caspase-9 and caspase-3 levels were suppressed by the addition of (20S)Rg 3 . (20S)Rg 3 prevents EC apoptosis http://ginsengres.org through the Akt-dependent inhibition of the mitochondrial apoptotic signaling pathway [14] . A dysfunction of ECs or apoptosis has been proposed to be an underlying mechanism in neurodegenerative disorders. For example, in AD dementia, the decreased clearing of β-amyloid deposits can contribute to the pathogenesis of this disorder [15, 16] .
In this study, we investigated the antisenescent and antiapoptotic activities of SG on EPCs, which may be potentially related to EC function in degenerative disorders, as well as in vascular repair.
MATERIALS AND METHODS

Materials
SG (Ginseng Science Inc., Seoul, Korea), endothelial basal medium (EBM-2, Clonetics Corporation, San Diego, CA, USA), EGM-2-MV-SingleQuots (Clonetics Corporation), fetal bovine serum (FBS, GIBCO, Invitrogen Corporation, Burlingame, CA, USA), FITC-labeled Ulex europaeus agglutinin I (ulex-lectin, Sigma-Aldrich Co., St. Louis, MO, USA), DiI-labeled acetylated lowdensity lipoprotein (acLDL; Invitrogen Corporation) [17] , Annexin V-FITC (BD Biosciences, San Jose, CA, USA), and Propidium iodide (PI, Sigma-Aldrich Co.) were used in this study.
Isolation and Characterization of EPCs
Human EPCs were cultured as previously described [18, 19] . Briefl y, EPCs were obtained by isolating mononuclear cells using a Ficoll density-gradient centrifugation of human blood buffy coats. Cells were resuspended in EBM-2 that was supplemented with EGM-2-MV-SingleQuots containing vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-1, epidermal growth factor, and 5% FBS. A total of 1 ×10 6 mononuclear cells/cm 2 was plated onto fi bronectincoated tissue culture fl asks. After 4 d of culture, nonadherent cells were discarded by washing with PBS. In order to confi rm the EPC phenotypes, adherent cells were incubated with DiI-labeled acLDL for 1 h. After fi xation, they were incubated with FITC-labeled ulex-lectin for 1 h. Cells were visualized with an inverted fluorescent microscope, and adherent cells that stained positive for both FITC-ulex-lectin and DiI-acLDL were determined to be EPCs. Blood samples were acquired with donors' consent, and the experimental procedures were approved by the institutional review board of Seoul National University Hospital.
Experimental protocol and treatment with SG
In order to determine the apoptotic and antiapoptotic effects of SG, a fl ow cytometric analysis was performed. Flow cytometry was performed on EPCs treated with vehicle or SG. In brief, EPCs were seeded onto a 6-well plate at a concentration of 1×10 5 , cultured for 4 days, and then treated with SG (200 μg/mL) [20, 21] after removal of the supernatant since there was the most effective at a dose of 200 μg/mL SG (data not shown). In 24 h, EPCs were stained with Annexin-V and PI after the detachment of cells with 0.25% trypsin-EDTA (Invitrogen Corporation).
A β-galactosidase (β-gal) assay was done in order to test for antiaging effects after the isolation of EPCs [22] . EPCs were plated on coverslips coated with poly-Llysine and cultured for 4 days. Cells were resuspended in media supplemented with SG and cultured for 24 h. The number of β-gal-stained cells (blue structures) was counted in 4 fi elds. The area of a fi eld was magnifi ed at 100X by an inverted microscope (BX61, Olympus Corporation, Tokyo, Japan).
Flow cytometric analysis
To analyze the patterns of apoptosis in EPCs after treatment with SG, a fl ow cytometric analysis was performed with cells after labeling with Annexin-V-FITC and PI. Adherent cells were collected, washed, and resuspended in cold binding buffer (PBS [pH 7.4], 140 mM NaCl, and 2.5 mM CaCl 2 ) and diluted to a fi nal concentration of 5×10 5 cells/mL. Aliquots of 1×10 5 cells were incubated with 0.5 μL of Annexin-V-FITC and 10 μL of PI per tube. After 15 min at room temperature, 400 μL of binding buffer was added before t he fl ow cytometric analysis. For each sample, 1×10 4 cells were analyzed on a FACS II fl ow cytometer (BD Biosciences). CellQuest TM Pro software (BD Biosciences) was used to perform the fl ow cytometric analysis.
Flow Cytometric Analysis of Annexin-V in EPCs
Annexin-V staining indicates the stages of cell death resulting from either apoptotic or necrotic processes. Cells in early apoptosis are Annexin-V-positive and PInegative, and cells that are in late apoptosis or are already dead are both Annexin-V-and PI-positive.
Cytochemical detection of β-gal staining
The monolayers of cells were washed 2 times with PBS and then fixed with 2% formaldehyde and 0.2% glutaraldehyde for 5 min. Staining solution was added [1 mg/mL 5-bromo-4-chloro-3-inolyl-β-D-galactosidase J. Ginseng Res. Vol. 36, No. 1, 78-85 (2012) (X-gal) in dimethylformamide, 40 mM citric acid/sodium phosphate, pH 6.0, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl, and 2 mM MgCl 2 ], and the cells were incubated at 37°C for 18 h. After incubation, the cells were washed 2 times with PBS.
Data analysis
All values are expressed as mean±standard deviation. The analysis was conducted using repeated measures of analysis of variance and an unpaired Student's t-test. A 2-tailed p-value less than 0.05 was considered to be signifi cant.
RESULTS
Culture and characterization of endothelial progenitor cells
On day 2, cultured peripheral blood mononuclear cells (PBMCs) were scattered on the culture plate, and on day 7, the cells showed the colony-forming units (CFU) or outgrowth cells (Fig. 1) . In previous study, the EPC-CFU numbers were developed to 72.4±24.5 when 1×10 4 EPCs derived from normal person were cultured in 12 wellplate [21, 23] . The EPCs exhibited a common endothelial phenotype that was defi ned by the uptake of acLDL and the binding of ulex-lectin [4, 6, 24] . In order to confirm the phenotypes of PBMCs cultured with EGM2MV, we subcultured CFU cells and stained them with acLDL and ulex-lectin. Fig. 2 shows that the subcultured CFU cells were positive for acLDL and showed ulex-lectin binding. The staining of nuclei with DAPI verifi ed that most adherent cells (93±2.7%) were acLDL-positive and ulexlectin-positive.
Senescence-associated β-gal staining in endothelial progenitor cells and eff ect of sun ginseng
In order to investigate the anti-senescent effect of SG, we compared the differences in β-gal-positive cell number between EPCs treated with SG (200 μg/mL) or vehicle for 24 h. The mean number of senescence-associated (SA)-β-gal-stained cells treated with SG was 62.5±3.6%, whereas that in controls was 93.8±2%. Compared with vehicle, SG resulted in a significant diminution of the proportion of SA-stained cells (p<0.001, Fig. 3B ).
The antiapoptotic eff ects of sun ginseng on endothelial progenitor cells
A fl ow cytometric analysis of Annexin-V-positive cells was performed in order to investigate the antiapoptotic effects of SG in EPCs. In control conditions, 4.9% of cells were undergoing late apoptotic cell death. EPCs treated with SG for 24 h had lower percentages of late apoptotic cells, with 3.0% in the late stage of apoptosis. Therefore, the population of apoptotic cells was reduced by SG compared to controls, which had 39% in late apoptosis (p<0.05) (Fig. 4) .
DISCUSSION
In this study, we attempted to test the antisenescent and antiapoptotic effects of SG on EPCs. The number of SA-β-gal staining-positive EPCs was lower after SG treatment than that with vehicle. Moreover, apoptotic cells were decreased in SG-treated EPCs compared to controls. Based on our data, SG appears to have effects on EPCs that involve both antisenescent and antiapoptotic mechanisms.
Recent studies have shown that degenerating neuronal cells display characteristics of apoptosis [25, 26] . Intrahippocampal injections of amyloid β peptide (Aβ) induced a spatial memory defi cit, apoptosis, and caspase-9 activation in hippocampal neurons [27] . Interference with or alterations of the Akt signaling pathway can be a feature in several neurodegenerative diseases that are characterized by neuronal attrition [28] [29] [30] . Therefore, reagents that suppress neuronal apoptosis have been developed as therapeutic agents in several neurodegenerative disorders [31, 32] . Panax ginseng has been reported to have an antiapoptotic effect in both in vivo and in vitro experiments [33] . In this experiment, SG lowered the number of Annexin-V-positive EPCs in a fl ow cytometric analysis [34, 35] , supporting the previous fi ndings that Rb 3 inhibited apoptosis [10] [11] [12] .
SG, which removes peroxide from the human body, has been reported to have strong antioxidant activities compared to the current ginsengs. SG also has effects on fatigue relief, antiaging, and improvements of circulation [21, 36] . Rg 3 in SG affects estrogen activity that reduces Cytochemically detectable β-gal staining at pH 6.0 was conducted as a marker of cellular senescence. Sun gineng-treated EPCs exhibit a lower level of SA β-gal staining than that of vehicle-treated controls (p<0.05). Vol. 36, No. 1, 78-85 (2012) EPC senescence through the augmentation of telomerase activity [37] . Therefore, it can be plausible that SG has effects on slowing senescence in EPCs, as shown with SA-β-gal staining [38] [39] [40] . In this study, we confirmed that SA β-gal staining in EPCs was decreased when compared to that of vehicle controls, indicating that SG has antisenescent effects on EPCs.
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Dementia is one of the most common human disorders associated with aging. AD, which is the most frequent type of dementia, exhibits degenerating neuronal loss in the brain [41, 42] . Amyloid plaques in the extracellular space are known to be the main mediator of the pathogenesis of AD [43, 44] . Circulating angiogenic cells (CACs), such as EPCs, have been shown to have functions in the clearance of amyloid β peptide (Aβ) [45, 46] . Therefore, endothelial senescence in AD is attributable to the faulty clearance of Aβ, which accelerates the progression of disease [47, 48] . CACs participate in the maintenance of the endothelium by replacing dysfunctional ECs or by releasing angiogenic growth factors [49, 50] . Recently, dysfunctions of EPCs have been proposed to be a cause of AD [9] . In addition, effi cacies of treatment with Korean red or Panax ginseng in patients with AD have been reported [51] , warranting a correlation study of ginsenosides, EPCs, and AD.
In conclusion, SG reduced the senescence and apoptosis in EPCs. Given that EPCs constitute a circulating pool of cells and augment neovascularization by integrating into newly developing capillaries [3,52,53], we suggest that SG can be an effective treatment for vascular repair and for disorders associated with the function and number of EPCs [3] [4] [5] [6] [7] 23, 54] .
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